Goldfine; IRA D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Goldfine; IRA D..The latest application filed is for "inhibitory effects of nordihydroguaiaretic acid (ndga) on the igf-1 receptor and androgen dependent growth of lapc-4 prostate cancer cells".

Company Profile

0.5.8

Goldfine; IRA D. - Belvedere CA
Goldfine; Ira D. - Tiburon CA
Goldfine, Ira D. - Kentfield CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitory Effects Of Nordihydroguaiaretic Acid (ndga) On The Igf-1 Receptor And Androgen Dependent Growth Of Lapc-4 Prostate Cancer Cells App 20090280112 - Goldfine; IRA D. ; et al.	2009-11-12
Small Molecule Potentiator Of Hormonal Therapy For Breast Cancer App 20080085874 - Kushner; Peter ; et al.	2008-04-10
Delivery of therapeutic gene products by intestinal cell expression App 20050026863 - German, Michael ; et al.	2005-02-03
Delivery of therapeutic gene products by intestinal cell expression Grant 6,831,070 - German , et al. December 14, 2	2004-12-14
Delivery of polypeptides by secretory gland expression App 20040127448 - German, Michael S. ; et al.	2004-07-01
Delivery of polypeptides by secretory gland expression App 20030078226 - German, Michael S. ; et al.	2003-04-24
Gene therapy by secretory gland expression App 20020193337 - German, Michael ; et al.	2002-12-19
Delivery of therapeutic gene products by intestinal cell expression App 20020039574 - German, Michael ; et al.	2002-04-04
Gene therapy by secretory gland expression App 20010036925 - German, Michael ; et al.	2001-11-01
Delivery of gene products by intestinal cell expression Grant 6,258,789 - German , et al. July 10, 2	2001-07-10
Gene delivery by secretory gland expression Grant 6,255,289 - German , et al. July 3, 2	2001-07-03
Systemic gene therapy by intestinal cell transformation Grant 6,225,290 - German , et al. May 1, 2	2001-05-01
Gene therapy by secretory gland expression Grant 5,885,971 - German , et al. March 23, 1	1999-03-23

Company Registrations

NCAGE Code	4TL47	GOLDFINE, IRA D
NCAGE Code	4VWR2	GOLDFINE IRA D
CAGE Code	4VWR2	GOLDFINE, IRA, D
CAGE Code	4TL47	GOLDFINE, IRA D

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.